1 / 4

Opioid Use Disorder Market Research and Forecast 2019-2025

The global opioid use disorder market is estimated to witness significant growth during the forecast period (2019-2025). Opioids are psychoactive substances derived from the opium poppy or their synthetic analogues. According to the Centers for Disease Control and Prevention (CDC), in 2016, 2.1 million people were suffering from opioid use disorder related to the prescribed opioids and 262,000 were suffering from OUD related to heroin in the US.

shriram01
Télécharger la présentation

Opioid Use Disorder Market Research and Forecast 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Orion Market Research Opioid Use Disorder Market Growth, Size, Share and Forecast 2019-2025 Request https://www.omrglobal.com/request-sample/opioid-use-disorder-market a free sample of our report on Opioid Use Disorder Market: ------------------------------------------------------------------------------------ Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +1 646-755-7667, +91 7803040404

  2. The global opioid use disorder market is estimated to witness significant growth during the forecast period (2019-2025). Opioids are psychoactive substances derived from the opium poppy or their synthetic analogues. According to the Centers for Disease Control and Prevention (CDC), in 2016, 2.1 million people were suffering from opioid use disorder related to the prescribed opioids and 262,000 were suffering from OUD related to heroin in the US. As per the American Psychiatric Association, in 2017, in the US, over 31,000 fatalities occurred from an opioid overdose, both prescribed and non- prescribed. Among this, over 16,000 fatalities occurred from the overdose of heroin and 15,000 people died from the overdose of prescribes opioids. A full report of Opioid Use Disorder Market is available at: https://www.omrglobal.com/industry- reports/opioid-use-disorder-market As per the available statistics, prescribed opioids are more harmful than the non-prescribed opioids. For instance, Fentanyl is 100 times more potent than morphine and 50 times more potent than heroin. During the Corona outbreak, the opioid epidemic became worse. In a recent publication of the National Public Radio (NPR), it is estimated that a large number of fatalities may occur due to opioid overdose. This is an opportunity in the growth of the global opioid use disorder market. The rising prevalence of opioid use disorder along with the new product launch by the key market players operating in the market is another major factor propelling the growth of the market. To learn more about this report request a free sample copy @ https://www.omrglobal.com/request- sample/opioid-use-disorder-market Indivior PLC, BioDelivery Sciences International, Inc., Teva Pharmaceuticals Inc., Alkermes, Inc., Titan Pharmaceuticals, Inc., Omeros Corporation, Hikma Pharmaceuticals PLC, Camurus, and so on are the key players operating in the opioid use disorder market. For instance, in September 2018, Teva Pharmaceuticals Inc. had received FDA approval for Cassipa sublingual film as a maintenance treatment for opioid dependence. Teva’s product contains 16 milligrams of buprenorphine and 4 milligrams of naloxone that offers a new strength of dosage for the treatment of opioid use disorder. In June 2018, Dr. Reddy’s Lab had received final approval from USFDA to launch Buprenorphine and Neloxon sublingual film 2.0 mg/0.5 mg, 4 mg/1 mg, 8Mg/2 mg, 12 mg/3 mg for use in the treatment of opioid use disorder. The growing FDA approval for new dosage strength is anticipated to offer significant growth opportunities to the opioid use disorder market across the globe.

  3. Current Market Trends Covered in the Market Report The adverse impact of high dosage of opioids is a key driving factor for the market growth. Side effects of the treatment may restrain market growth. New product launches to provide opportunities for market growth. Global Opioid Use Disorder Market Segmentation By Drug Types Methadone Buprenorphine Naltrexone For more customized data, request for report customization @ https://www.omrglobal.com/report- customization/opioid-use-disorder-market Global Opioid Use Disorder Market – Segment by Region North America United States Canada Europe Germany United Kingdom France Spain Italy Rest of Europe Asia-Pacific China Japan India Rest of Asia-Pacific

  4. Rest of the World Middle East & Africa Latin America Company Profiles Alkermes, PLC. BioDelivery Sciences International, Inc. Camurus AB Hikma Pharmaceuticals PLC Indivior PLC Mallinckrodt Co. Masimo Corp. MediciNova, Inc. Mylan N.V. Novartis AG Omeros Corp. Orexo US, Inc. Teva Pharmaceuticals Industrial, Ltd. Titan Pharmaceuticals, Inc. About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. For More Information, Visit Orion Market Research Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 7803-040-404

More Related